Charles Schwab’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $809K | Buy |
244,396
+33,697
| +16% | +$112K | ﹤0.01% | 2967 |
|
|
2025
Q1 | $611K | Buy |
210,699
+30
| +0% | +$87 | ﹤0.01% | 3012 |
|
|
2024
Q4 | $750K | Buy |
210,669
+7,129
| +4% | +$25.4K | ﹤0.01% | 3011 |
|
|
2024
Q3 | $1.01M | Buy |
203,540
+9,268
| +5% | +$46.2K | ﹤0.01% | 2911 |
|
|
2024
Q2 | $505K | Buy |
194,272
+175,194
| +918% | +$456K | ﹤0.01% | 3193 |
|
|
2024
Q1 | $81.3K | Hold |
19,078
| – | – | ﹤0.01% | 3326 |
|
|
2023
Q4 | $38.5K | Hold |
19,078
| – | – | ﹤0.01% | 3426 |
|
|
2023
Q3 | $29.2K | Hold |
19,078
| – | – | ﹤0.01% | 3471 |
|
|
2023
Q2 | $31.5K | Buy |
+19,078
| New | +$31.5K | ﹤0.01% | 3496 |
|
|
2021
Q3 | – | Sell |
-74,757
| Closed | -$297K | – | 3502 |
|
|
2021
Q2 | $297K | Sell |
74,757
-97,940
| -57% | -$389K | ﹤0.01% | 3241 |
|
|
2021
Q1 | $899K | Sell |
172,697
-8,413
| -5% | -$43.8K | ﹤0.01% | 2894 |
|
|
2020
Q4 | $969K | Hold |
181,110
| – | – | ﹤0.01% | 2783 |
|
|
2020
Q3 | $880K | Buy |
181,110
+127,202
| +236% | +$618K | ﹤0.01% | 2705 |
|
|
2020
Q2 | $262K | Buy |
+53,908
| New | +$262K | ﹤0.01% | 3103 |
|
|
2019
Q2 | – | Sell |
-23,379
| Closed | -$162K | – | 3215 |
|
|
2019
Q1 | $162K | Buy |
+23,379
| New | +$162K | ﹤0.01% | 3051 |
|